Abstract
A prospective double-blind trial of aspirin prophylaxis demonstrated a reduction of more than 50% in headache frequency in 9 of 12 migraine patients. Response to aspirin did not correlate with age, duration of headache history, family history, or platelet ultrastructure. There is some evidence that response to aspirin is associated with raised platelet aggregation. This pilot study indicates that aspirin is effective in migraine prophylaxis.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adolescent
-
Adult
-
Aspirin / administration & dosage
-
Aspirin / therapeutic use*
-
Clinical Trials as Topic
-
Double-Blind Method
-
Female
-
Humans
-
Male
-
Middle Aged
-
Migraine Disorders / blood
-
Migraine Disorders / epidemiology
-
Migraine Disorders / prevention & control*
-
Placebos
-
Platelet Aggregation / drug effects
-
Prospective Studies
-
Time Factors